Latin America Continuous Glucose Monitoring Device Market

Continuous glucose monitoring devices are considered as significant systems for improving diabetes management by providing better and pain-free blood glucose measurement. Continuous glucose monitoring devices marked a remarkable change in diabetes care, as these devices provide real-time information on blood glucose levels, non-invasively than conventional glucose monitoring devices. Continuous glucose monitoring devices constantly tracks the blood glucose level throughout the day. This device consists of various components such as sensors, transmitters, and receivers for measuring and analyzing the glucose levels.

Market Dynamics

Latin America continuous glucose monitoring device market is expected to witness significant growth over the forecast period, owing to increasing incidence of diabetes in Latin American countries which may result in increasing demand for continuous glucose monitoring device. For instance, in September 2019, according to report published in the International Journal of Diabetes and Clinical Research, Mexico (13.6%) had the highest prevalence of diabetes, whereas significant differences between urban and rural areas were observed (7.8% and 1.4%, respectively) in Latin America. Latin America had the maximum prevalence of type-2 Diabetes problems.

Furthermore, increasing convenience offered by continuous glucose monitoring devices is expected to drive the growth of the Latin America continuous glucose monitoring device market, as display of glucose trend graph and direction arrows allow diabetic patients to anticipate deflection in glucose highs and lows regularly throughout the day, this may increase demand for continuous glucose monitoring devices, which in turn is expected to drive the market growth. Moreover, technological advancements in continuous glucose monitoring components such as use of sensor with long life expectancy in continuous monitoring devices that eliminates the repetitive replacement of sensors is expected to generate remarkable revenue in the market over the forecast period.

Key features of the study:

• This report provides an in-depth analysis of the Latin America continuous glucose monitoring device market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Latin America continuous glucose monitoring device market  based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Medtronic Plc., Abbott, F. Hoffmann-La Roche AG., Johnson & Johnson, Senseonics, Inc, Dexcom, Inc, Insulet Corporation, Tandem Diabetes Care, Inc, Roche Diagnositics, Lifescan, Bayer Health Care, AgaMatrixc Inc., Arkray Inc., and Nova Biomedical Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Latin America continuous glucose monitoring device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the  Latin America continuous glucose monitoring device market

Detailed Segmentation:

•  Latin America Continuous Glucose Monitoring Device Market, By Component Type:
  • Transmitters
  • Receivers
  • Insulin Pumps
  • Sensors
•  Latin America Continuous Glucose Monitoring Device Market, By End User:
  • Hospitals & Clinics
  • Homecare
  • Others (Ambulatory Surgical Centers & Academic Institutes)
• Latin America Continuous Glucose Monitoring Device Market, By Country:
  • Mexico
  • Argentina
  • Uruguay
  • Brazil
  • Colombia
  • Chile
  • Peru
  • Rest of Latin America
• Company Profiles
  • Medtronic Plc*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Abbott
  • Hoffmann-La Roche AG.
  • Johnson & Johnson
  • Senseonics, Inc
  • Dexcom, Inc
  • Insulet Corporation
  • Tandem Diabetes Care, Inc
  • Roche Diagnositics
  • Lifescan
  • Bayer Health Care
  • AgaMatrixc Inc.
  • Arkray Inc.
  • Nova Biomedical Corporation

 “*” marked represents similar segmentation in other categories in the respective section.